Looking for links in all the wrong places? Just click “more”!
Continue reading “Unrequired Reading: Aug. 7, 2009”

A podcast about books, art & life — not necessarily in that order
Looking for links in all the wrong places? Just click “more”!
Continue reading “Unrequired Reading: Aug. 7, 2009”
Another day, another pinko leftist newspaper railing about income inequality and how it demolishes the Social Security fund:
Executives and other highly compensated employees now receive more than one-third of all pay in the U.S., according to a Wall Street Journal analysis of Social Security Administration data — without counting billions of dollars more in pay that remains off federal radar screens that measure wages and salaries.
. . . The growing portion of pay that exceeds the maximum amount subject to payroll taxes has contributed to the weakening of the Social Security trust fund. In May, the government said the Social Security fund would be exhausted in 2037, four years earlier than was predicted in 2008.
I was going to go into a whole Colbertian ramble on the left-wing moonbats at the Wall Street Journal, but frankly it’s just a good article about the ramifications of executive pay scales. Give it a read.
Summertime, and the linkin’ is easy. Just click “more”!
Continue reading “Unrequired Reading: July 17, 2009”
What I’m reading: Killshot, by Elmore Leonard, and Asterios Polyp
, by David Mazzucchelli.
What I’m listening to: LP by Discovery, which was okay, but a little too deliberately like a poor man’s Postal Service
.
What I’m watching: Just The Tall Guy (one of my favorite movies back in college, but one I haven’t watched in at least a decade), and this week’s Deadliest Catch. Amy had a pretty late work-week, and I tend not to watch a lot of stuff by myself.
What I’m drinking: Plymouth & Q Tonic.
What Rufus is up to: Making his first foray into a lake.
Where I’m going: Back to the office! Eek!
What I’m happy about: That I managed to reduce my daily caffeine intake by more than 50% during this vacation! (Also, that I managed to clear around 225 square feet of my backyard by pulling up rampant forsythia, cleaned out my garage, took care of a ton of other items on my to-do list, and still got to spend time with my brother & his family.)
What I’m sad about: That the downstairs freezer and the washing machine both crapped out last week. We got a new washer on Sunday and have a repair guy coming next week for the freezer.
What I’m worried about: Getting back into the rhythm of working at my office, as opposed to working at home.
What I’m pondering: How much of my Top Companies issue will be out of date by the time it sees print.
The production schedule read, “Final Materials to Printer – July 2,” and I’m gonna get those final materials to the printer by July 2! Just a couple hundred words more about Pfizer and a brief writeup about Abbott Laboratories, and this year’s Top 20 Pharma / Top 10 Biopharma ish will be finished!
So don’t expect any more posts today.
In other news, it looks like the constant dreariness and rainfall of June has had at least one positive effect: the deer have had enough to eat in the woods and have (mostly) left my tigerlilies alone!
No doubt about it: these links suck. Just click “more”!
Continue reading “Unrequired Reading: June 26, 2009”
A “Key Figure” from sanofi-aventis’ annual report:
The title of this post is from one of my favorite Woody Allen movies. Relax: I don’t expect any of you to get that one.
(UPDATE: Summamabitch! sanofi got revenge on me! I was about 80% of the way through its profile, for an issue that goes to press early next week, when I got a pharma e-newsletter with a link to the following item:
Sanofi-Aventis Plans Job Cuts
M2 Europharma – Jun. 22, 2009
22 June 2009 -French pharmaceutical group Sanofi-Aventis (EPA: SAN) may further cut jobs after the 927 lay-offs in 2008, business daily Les Echos reported on Monday (22 June), quoting trade union sources.
Sanofi-Aventis management is expected to announce the plans for major restructuring at an extraordinary works council next week. Employees are particularly concerned over positions in the research divisions.
The drug maker has been affected by the launch of generic versions of some of its key medicines. Within the coming months the generic version of its anti-cancer drug Eloxatin should …
Of course, the full announcement’s only going to come after the company’s profile is off at the printer! Grr!)
Hot off the presses! Or my RSS reader. Whatever. Just click “more”!
Continue reading “Unrequired Reading: June 19, 2009”
In the “I wish I’d made this up” department, the following press release just rolled through my healthcare newswire:
GLASGOW, Scotland, June 17 /PRNewswire/ — Transform Cosmetic Surgery Group has revealed that despite the drooping economy Scots men are opting to perk themselves up this summer by booking in for moob removal surgery and finally getting their insecurities off their chests.
Transform revealed that although there has been a 44 per cent increase in the procedure across the UK, the group’s Scottish clinics have seen the popularity of the procedure increase by 80 per cent from 2007 with 40 operations being carried out in 2008 compared to 2007’s 22.
Transform’s Scottish clinics also found that the number of enquiries for the procedure ballooned in the spring time from men who were preparing to shed layers of clothing during the Scottish summer months.
You really need to read the whole thing. I guess I need to have Boob Week on this site sometime.